Beier N - Search Results

1

Three thiadiazinone derivatives, EMD 60417, EMD 66430, and EMD 66398, with class III antiarrhythmic activity but different electrophysiologic profiles.

Himmel HM, Wettwer E, Lues I, Beier N, Jonas R, Ravens U. Himmel HM, et al. Among authors: beier n. J Cardiovasc Pharmacol. 2001 Sep;38(3):438-49. doi: 10.1097/00005344-200109000-00012. J Cardiovasc Pharmacol. 2001. PMID: 11486248

2

The novel cardiotonic agent EMD 53 998 is a potent "calcium sensitizer".

Beier N, Harting J, Jonas R, Klockow M, Lues I, Haeusler G. Beier N, et al. J Cardiovasc Pharmacol. 1991 Jul;18(1):17-27. doi: 10.1097/00005344-199107000-00004. J Cardiovasc Pharmacol. 1991. PMID: 1719287

3

The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers.

Lues I, Beier N, Jonas R, Klockow M, Haeusler G. Lues I, et al. Among authors: beier n. J Cardiovasc Pharmacol. 1993 Jun;21(6):883-92. doi: 10.1097/00005344-199306000-00006. J Cardiovasc Pharmacol. 1993. PMID: 7687712

4

Novel diazinone derivatives separate myofilament Ca2+ sensitization and phosphodiesterase III inhibitory effects in guinea pig myocardium.

Ventura C, Miller R, Wolf HP, Beier N, Jonas R, Klockow M, Lues I, Hano O, Spurgeon HA, Lakatta EG, et al. Ventura C, et al. Among authors: beier n. Circ Res. 1992 Jun;70(6):1081-90. doi: 10.1161/01.res.70.6.1081. Circ Res. 1992. PMID: 1533576

5

Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives.

Mederski WW, Dorsch D, Bokel HH, Beier N, Lues I, Schelling P. Mederski WW, et al. Among authors: beier n. J Med Chem. 1994 May 27;37(11):1632-45. doi: 10.1021/jm00037a014. J Med Chem. 1994. PMID: 8201597

6

Inhibitors of ischemic preconditioning do not attenuate Na+/H+ exchange inhibitor mediated cardioprotection.

Gumina RJ, Beier N, Schelling P, Gross GJ. Gumina RJ, et al. Among authors: beier n. J Cardiovasc Pharmacol. 2000 Jun;35(6):949-53. doi: 10.1097/00005344-200006000-00019. J Cardiovasc Pharmacol. 2000. PMID: 10836732

7

A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered before or after coronary artery occlusion.

Gumina RJ, Mizumura T, Beier N, Schelling P, Schultz JJ, Gross GJ. Gumina RJ, et al. Among authors: beier n. J Pharmacol Exp Ther. 1998 Jul;286(1):175-83. J Pharmacol Exp Ther. 1998. PMID: 9655858

8

Pharmacokinetic/pharmacodynamic evaluation of the NHE inhibitor eniporide.

Kovar A, Peters T, Beier N, Derendorf H. Kovar A, et al. Among authors: beier n. J Clin Pharmacol. 2001 Feb;41(2):139-48. doi: 10.1177/00912700122009944. J Clin Pharmacol. 2001. PMID: 11210393 Clinical Trial.

9

Interaction of cardiac troponin C with Ca(2+) sensitizer EMD 57033 and cardiac troponin I inhibitory peptide.

Li MX, Spyracopoulos L, Beier N, Putkey JA, Sykes BD. Li MX, et al. Among authors: beier n. Biochemistry. 2000 Aug 1;39(30):8782-90. doi: 10.1021/bi000473i. Biochemistry. 2000. PMID: 10913289

10

Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments.

Solaro RJ, Gambassi G, Warshaw DM, Keller MR, Spurgeon HA, Beier N, Lakatta EG. Solaro RJ, et al. Among authors: beier n. Circ Res. 1993 Dec;73(6):981-90. doi: 10.1161/01.res.73.6.981. Circ Res. 1993. PMID: 8222092

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters